Contact
Please use this form to send email to PR contact of this press release:
CytoDyn Receives Positive DSMC Recommendation for Leronlimab Phase 3 COVID-19 Trial with No Safety Concerns
TO:
Please use this form to send email to PR contact of this press release:
CytoDyn Receives Positive DSMC Recommendation for Leronlimab Phase 3 COVID-19 Trial with No Safety Concerns
TO: